ストックスクリーナーアプリを入手
0.881
2.48%
0.0213
前日終値:
$0.8597
開ける：
$0.8196
24時間の取引高:
45,861
Relative Volume:
0.17
時価総額：
$35.70M
収益：
$4.14M
当期純損益:
$-3.19M
株価収益率:
-1.1792
EPS:
-0.7471
ネットキャッシュフロー:
$11,000
1週間 パフォーマンス:
+17.06%
1か月 パフォーマンス:
+67.08%
6か月 パフォーマンス:
-51.06%
1年 パフォーマンス:
-45.95%
1日の値動き範囲:
$0.7839
$0.883
1週間の範囲:
$0.7512
$0.883
52週間の値動き範囲:
$0.3818
$2.05
China Pharma Holdings Inc. Stock (CPHI) Company Profile
名前
China Pharma Holdings Inc.
セクター
電話
86 898 6681 1730
住所
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.881 | 34.84M | 4.14M | -3.19M | 11,000 | -0.7471 |
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.96B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.72 | 38.49B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.83 | 38.52B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.59 | 32.02B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.47 | 22.92B | 3.17B | 1.29B | 1.01B | 27.09 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2010-01-08 | 開始されました | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. (CPHI) 最新ニュース
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
China NT Pharma Group Announces Proposed Disposal of NT Pharma (Overseas) Holding Co., Ltd Equity Interests to Alleviate Liquidity Strain 12 - Minichart
KOP Q1 2026 Earnings: EPS Surprises by Nearly 30% Amid Revenue Silence, Stock SlipsEstimate Uncertainty - thelegaladvocate.com
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Udemy Inc. (UDMY) Stabilizes Near Support as Market Awaits CatalystChandelier Stop - thelegaladvocate.com
China Pharma Company Profile & Introduction - Moomoo
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says - Yahoo Finance
China Pharma Holdings (CPHI) Q3 2011 Earnings: EPS Miss Weighs on SentimentEPS Guidance Update - newsline.com
ePlus inc. (PLUS) Q1 2026 Earnings: EPS Surges 40.75% Above Estimates, Stock RisesPreliminary Results - thelegaladvocate.com
Rafael Holdings (RFL) Sees Modest Uptick, Testing Key Resistance at $1.41MA Cross Alert - thelegaladvocate.com
CPHI Stock Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
Sono Group (SSM) Surges +6.29%, Nearing $4.35 Resistance 2026-05-18BPI Reversal - thelegaladvocate.com
China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity - digitalmore.co
China Pharma says unaware of reason for unusual trading - Investing.com
China Pharma says unaware of reason for unusual trading By Investing.com - Investing.com Nigeria
China Pharma Holdings IncNYSE American contacts China Pharma regarding unusual market activity on May 12 and 13 - marketscreener.com
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
TradingKey - TradingKey
These stocks are moving in today's after hours session - ChartMill
C3 AI Announces Q4 and Fiscal Year 2026 Preliminary Results: Tom Siebel Returns as CEO, Reports Revenue Within Guidance and Improved Operating Losses - Minichart
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
China NT Pharma Group Company Limited Announces Board and Committee Changes, Effective May 8, 2026 - marketscreener.com
CPHI PE Ratio & Valuation, Is CPHI Overvalued - Intellectia AI
China NT Pharma Group Quarterly Update on Action Plans for Disclaimer of Opinion Resolution and AI Health Business Transformation 1 - Minichart
Chinese firm Livzon secures control of Vietnam’s pharma giant Imexpharm in $228 mln deal - Theinvestor
Why Seagate Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Top LosersStock ScreenerSnapshot - Finviz
CPHI Technical Analysis & ETF Price Forecast - Intellectia AI
EBITDA per share of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
EBIT per share of China Pharma Holdings, Inc. – MUN:XQJ0 - TradingView
Regeneron CEO Defends Pharma, Warns China Will ‘Pass Us Right By’ After Announcing Free Gene Therapy For Hearing Loss - Stocktwits
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by China Universal Asset Management Co. Ltd. - MarketBeat
Shuttle Pharma (SHPH) proxy asks investors to OK major reverse split range - Stock Titan
China Pharma (CPHI) Stock Dividend Analysis (+1.54%) 2026-04-16Price Action - Cổng thông tin điện tử tỉnh Lào Cai
China Pharma Holdings, Inc. (CPHI) - Minichart
Trading Recap: Does ALLT have strong EBITDA margins2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
Aug Sentiment: Why is Alexanders Inc stock going downProduct Launch & Weekly High Momentum Picks - baoquankhu1.vn
Is China Pharma (CPHI) Stock a Growth Play | Price at $0.65, Up 0.62%NHNL Divergence - thelegaladvocate.com
symbol__ Stock Quote Price and Forecast - CNN
US Market Recap: Can PBHC generate free cash flowLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Is China Pharma (CPHI) Stock defensive in downturns | Price at $0.60, Down 2.42%VOLD Alert - thelegaladvocate.com
Ascentage Pharma Group International (NASDAQ:AAPG) Raised to "Strong-Buy" at China Intl Cap - MarketBeat
Is Quantum-Si Incorporated (QSI) Stock tied to economic cycles | QSI Q4 Earnings: Beats Estimates by $0.04Sell Rating - Xã Châu Thành
Market Catalysts: Is China Pharma Holdings Incs ROE strong enough2026 Volume Leaders & High Conviction Trade Alerts - baoquankhu1.vn
Earnings Risk: Can China Pharma Holdings Inc expand its profit marginsVolume Spike & Low Drawdown Trading Strategies - baoquankhu1.vn
Is Check Point (CHKP) Stock Breaking Resistance | Price at $147.63, Down 0.40%Anchored VWAP - thelegaladvocate.com
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison - Defense World
CUPR PE Ratio & Valuation, Is CUPR Overvalued - Intellectia AI
China Pharma Holdings Inc. (CPHI) 財務データ
収益
当期純利益
現金流量
EPS
0.08%
2.59%
大文字化:
|
ボリューム (24 時間):